Michael Fehlings

3.7k total citations
21 papers, 756 citations indexed

About

Michael Fehlings is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Michael Fehlings has authored 21 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 9 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Michael Fehlings's work include Immune Cell Function and Interaction (9 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Immunotherapy and Immune Responses (7 papers). Michael Fehlings is often cited by papers focused on Immune Cell Function and Interaction (9 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Immunotherapy and Immune Responses (7 papers). Michael Fehlings collaborates with scholars based in Singapore, United States and United Kingdom. Michael Fehlings's co-authors include Evan W. Newell, Alessandra Nardin, Yannick Simoni, Hermi Sumatoh, Stephen T. Oh, Olga Malkova, Ekaterina Esaulova, Elise Alspach, Catrina C. Fronick and Pamela Wong and has published in prestigious journals such as Cell, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Michael Fehlings

20 papers receiving 750 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Fehlings Singapore	10	442	370	217	134	62	21	756
Elisabetta Dondi France	15	348 0.8×	256 0.7×	218 1.0×	72 0.5×	42 0.7×	34	723
James Strauss United States	14	370 0.8×	394 1.1×	224 1.0×	92 0.7×	76 1.2×	69	837
James M. Leatherman United States	13	443 1.0×	461 1.2×	271 1.2×	33 0.2×	93 1.5×	26	814
Emily F. Higgs United States	7	421 1.0×	336 0.9×	207 1.0×	72 0.5×	52 0.8×	15	619
Cecilia Rietz United States	9	611 1.4×	694 1.9×	178 0.8×	56 0.4×	51 0.8×	13	973
Vincent Vanheule Belgium	11	270 0.6×	253 0.7×	191 0.9×	36 0.3×	32 0.5×	16	579
Uxua Mancheño Spain	14	350 0.8×	343 0.9×	192 0.9×	45 0.3×	26 0.4×	19	623
Jean‐Christophe Beltra United States	8	737 1.7×	595 1.6×	195 0.9×	27 0.2×	54 0.9×	9	962
Kijong Yi South Korea	10	160 0.4×	204 0.6×	244 1.1×	56 0.4×	144 2.3×	12	578
Wilhem Leconet France	11	178 0.4×	232 0.6×	141 0.6×	78 0.6×	34 0.5×	12	514

Countries citing papers authored by Michael Fehlings

Since Specialization

Citations

This map shows the geographic impact of Michael Fehlings's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Fehlings with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Fehlings more than expected).

Fields of papers citing papers by Michael Fehlings

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Fehlings. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Fehlings. The network helps show where Michael Fehlings may publish in the future.

Co-authorship network of co-authors of Michael Fehlings

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Fehlings. A scholar is included among the top collaborators of Michael Fehlings based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Fehlings. Michael Fehlings is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fehlings, Michael, et al.. (2025). The management of odontoid fractures through the lens of evolution in classification schemes: A systematic review with illustrative case examples. Brain and Spine. 5. 104205–104205.

Tay, Timothy Kwang Yong, Enya H.W. Ong, Michael Fehlings, et al.. (2024). Combinatorial hypofractionated radiotherapy and pembrolizumab in anaplastic thyroid cancer. European Thyroid Journal. 13(1). 8 indexed citations

Wolz, Olaf‐Oliver, Dominik Vahrenhorst, Gianluca Quintini, et al.. (2024). Innate Responses to the Former COVID-19 Vaccine Candidate CVnCoV and Their Relation to Reactogenicity and Adaptive Immunogenicity. Vaccines. 12(4). 388–388. 1 indexed citations

Schmidt, Florian, Kan Xing Wu, Yannick Simoni, et al.. (2023). In-depth analysis of human virus-specific CD8+ T cells delineates unique phenotypic signatures for T cell specificity prediction. Cell Reports. 42(10). 113250–113250. 11 indexed citations

Leung, Elaine Lai‐Han, Runze Li, Xing‐Xing Fan, et al.. (2023). Longitudinal high-dimensional analysis identifies immune features associating with response to anti-PD-1 immunotherapy. Nature Communications. 14(1). 5115–5115. 14 indexed citations

Fehlings, Michael, Leesun Kim, Xiangnan Guan, et al.. (2022). Single-cell analysis reveals clonally expanded tumor-associated CD57 ⁺ CD8 T cells are enriched in the periphery of patients with metastatic urothelial cancer responding to PD-L1 blockade. Journal for ImmunoTherapy of Cancer. 10(8). e004759–e004759. 26 indexed citations

Redd, Andrew D., Alessandra Nardin, Hassen Kared, et al.. (2022). Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8 ⁺ T-Cell Epitopes Identified in COVID-19 Convalescent Individuals. mBio. 13(2). e0361721–e0361721. 64 indexed citations

Redd, Andrew D., Alessandra Nardin, Hassen Kared, et al.. (2021). CD8+ T-Cell Responses in COVID-19 Convalescent Individuals Target Conserved Epitopes From Multiple Prominent SARS-CoV-2 Circulating Variants. Open Forum Infectious Diseases. 8(7). ofab143–ofab143. 63 indexed citations

DeGottardi, Quinn, Junbao Yang, Eddie A. James, et al.. (2020). Ontogeny of different subsets of yellow fever virus-specific circulatory CXCR5+ CD4+ T cells after yellow fever vaccination. Scientific Reports. 10(1). 15686–15686. 7 indexed citations

10.

Chiu, David Kung‐Chun, Vincent Wai‐Hin Yuen, Jacinth Wing‐Sum Cheu, et al.. (2020). Hepatocellular Carcinoma Cells Up-regulate PVRL1, Stabilizing PVR and Inhibiting the Cytotoxic T-Cell Response via TIGIT to Mediate Tumor Resistance to PD1 Inhibitors in Mice. Gastroenterology. 159(2). 609–623. 129 indexed citations

11.

Singh, Alveera, Paul Ogongo, Julia Roider, et al.. (2020). Unbiased Profiling Reveals Compartmentalization of Unconventional T-Cells Within the Intestinal Mucosa Irrespective of HIV Infection. Frontiers in Immunology. 11. 579743–579743. 7 indexed citations

12.

Fehlings, Michael, Suchit Jhunjhunwala, Marcin Kowanetz, et al.. (2019). Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in peripheral blood of non-small cell lung carcinoma patients responding to atezolizumab treatment. Journal for ImmunoTherapy of Cancer. 7(1). 249–249. 56 indexed citations

13.

Simoni, Yannick, Michael Fehlings, & Evan W. Newell. (2019). Multiplex MHC Class I Tetramer Combined with Intranuclear Staining by Mass Cytometry. Methods in molecular biology. 1989. 147–158. 8 indexed citations

14.

Fehlings, Michael, Alessandra Nardin, Suchit Jhunjhunwala, et al.. (2019). Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in non-small cell lung carcinoma patients responding to atezolizumab treatment. European Journal of Cancer. 110. S2–S3. 2 indexed citations

15.

Newell, Evan W., et al.. (2019). Immune profiling of tumor-infiltrating T cells using mass cytometry.. Journal of Clinical Oncology. 37(15_suppl). 2607–2607. 1 indexed citations

16.

Gubin, Matthew M., Ekaterina Esaulova, Jeffrey P. Ward, et al.. (2018). High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy. Cell. 175(4). 1014–1030.e19. 275 indexed citations

17.

Simoni, Yannick, Melissa Hui Yen Chng, Shamin Li, Michael Fehlings, & Evan W. Newell. (2018). Mass cytometry: a powerful tool for dissecting the immune landscape. Current Opinion in Immunology. 51. 187–196. 65 indexed citations

18.

Fehlings, Michael, Svetoslav Chakarov, Yannick Simoni, et al.. (2017). Multiplex peptide-MHC tetramer staining using mass cytometry for deep analysis of the influenza-specific T-cell response in mice. Journal of Immunological Methods. 453. 30–36. 11 indexed citations

19.

Chruscinski, Andrzej, Flora Huang, Antigona Ulndreaj, et al.. (2016). Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies. Journal of Visualized Experiments. 5 indexed citations

20.

Fehlings, Michael, Macarena Beigier‐Bompadre, Verena Moos, et al.. (2016). Usage of murine T-cell hybridoma cells as responder cells reveals interference of Helicobacter pylori with human dendritic cell-mediated antigen presentation. European Journal of Microbiology and Immunology. 6(4). 306–311. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact